dōTERRA International
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, dōTERRA International sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
dōTERRA International: 8 sponsored US clinical trials, 1 recruiting.
dōTERRA International sponsors 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Healthy, with 1 trials.
Upper-quartile sponsor footprint
dōTERRA International sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Efficacy and Safety of an Essential Oil-Based Product System for Immune Support
NCT07482644
Essential Oil Inhalation and Acute Stress Response in Healthy Adults
NCT07473544
Essential Oil-Based Product System for Digestive Support
NCT07653815
Natural Product System and Lifestyle Modification
NCT06931977
Frankincense Supplements and Inflammation
NCT06488417
Omega-3 Supplement and Health Markers
NCT06492694
Lavender Essential Oil-based Product System for Sleep
NCT06510335
Effects of a Novel Supplement on Glycemic Variability Measured by Continuous Glucose Monitoring
NCT05832463
Therapeutic Areas
What is open in the dōTERRA International pipeline
1 recruiting of 8 indexed (13% open); 5 completed (63%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Healthy (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
dōTERRA International: open-pipeline peers nationwide
Peers matched on 8 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
dōTERRA International sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this dōTERRA International page
8 registered trials is a research-attention snapshot, not an endorsement of dōTERRA International or any single study.
- 1 of dōTERRA International's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition dōTERRA International studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. dōTERRA International pipeline card: 8 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.